Detection of hepatitis B virus core mutants by PCR-RFLP in chronically infected patients

M F Barros1, P A Rodrigues, S R Matias

  • 1Immunology Department, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo de Santana 130, 1169-056 Lisbon, Portugal. imunologia@fcm.unl.pt

Insights

Chronic hepatitis B virus (HBV) infection is a significant health concern. This study identified common mutations in the HBV core antigen gene, offering a rapid detection method for viral mutants in patients.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Chronic hepatitis B virus (HBV) infection poses a major global health challenge.
  • The HBV core antigen is vital for immune recognition, influencing infection outcomes.
  • Understanding HBV genetic variations is crucial for managing chronic infection.

Purpose of the Study:

  • To detect and characterize point mutations within the HBV core open reading frame (ORF).
  • To evaluate the frequency of specific HBV core gene mutations in chronically infected individuals.
  • To establish a rapid and reliable method for identifying HBV mutants.

Main Methods:

  • Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) was employed to analyze HBV DNA from patient serum.
  • Direct sequencing confirmed PCR-RFLP findings for HBV DNA from chronically infected patients.
  • A longitudinal study design was used to track viral changes in a subset of patients.

Main Results:

  • Frequent mutations were identified at positions 2248 and 2147 (designated A3), and at position 2038 (designated M2).
  • The wild-type HBV core genotype was present in approximately 50% of the analyzed samples.
  • PCR-RFLP proved to be a rapid and reliable technique for mutation detection.

Conclusions:

  • Specific point mutations in the HBV core gene are common in chronically infected patients.
  • PCR-RFLP offers an efficient method for detecting HBV viral mutants.
  • This approach can aid in the rapid screening of large patient cohorts for HBV variants.